[DPHARMA] QoQ Annualized Quarter Result on 31-Mar-2022 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-May-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
31-Mar-2022 [#1]
Profit Trend
QoQ- 23.57%
YoY- 15.2%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 696,717 726,342 735,366 743,764 639,175 658,308 643,786 5.39%
PBT 84,851 92,672 96,238 106,584 82,983 87,808 86,746 -1.45%
Tax -14,739 -22,070 -23,034 -25,420 -17,300 -21,185 -20,738 -20.30%
NP 70,112 70,601 73,204 81,164 65,683 66,622 66,008 4.09%
-
NP to SH 70,112 70,601 73,204 81,164 65,683 66,622 66,008 4.09%
-
Tax Rate 17.37% 23.82% 23.93% 23.85% 20.85% 24.13% 23.91% -
Total Cost 626,605 655,741 662,162 662,600 573,492 591,685 577,778 5.54%
-
Net Worth 657,045 647,522 634,375 621,987 621,564 612,147 614,350 4.56%
Dividend
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Div 21,901 6,348 9,468 - 21,660 6,278 7,061 112.24%
Div Payout % 31.24% 8.99% 12.93% - 32.98% 9.42% 10.70% -
Equity
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Net Worth 657,045 647,522 634,375 621,987 621,564 612,147 614,350 4.56%
NOSH 952,239 952,239 952,239 941,765 941,765 941,765 706,330 21.97%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 10.06% 9.72% 9.95% 10.91% 10.28% 10.12% 10.25% -
ROE 10.67% 10.90% 11.54% 13.05% 10.57% 10.88% 10.74% -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 73.17 76.28 77.67 80.12 67.87 69.90 91.17 -13.60%
EPS 7.39 7.45 7.76 8.76 6.98 7.08 9.34 -14.41%
DPS 2.30 0.67 1.00 0.00 2.30 0.67 1.00 73.97%
NAPS 0.69 0.68 0.67 0.67 0.66 0.65 0.87 -14.28%
Adjusted Per Share Value based on latest NOSH - 941,765
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 72.43 75.51 76.45 77.32 66.45 68.44 66.93 5.39%
EPS 7.29 7.34 7.61 8.44 6.83 6.93 6.86 4.12%
DPS 2.28 0.66 0.98 0.00 2.25 0.65 0.73 113.22%
NAPS 0.683 0.6731 0.6595 0.6466 0.6462 0.6364 0.6387 4.55%
Price Multiplier on Financial Quarter End Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 -
Price 1.61 1.30 1.20 1.49 1.68 1.81 3.03 -
P/RPS 2.20 1.70 1.55 1.86 2.48 2.59 3.32 -23.93%
P/EPS 21.87 17.53 15.52 17.04 24.09 25.59 32.41 -23.01%
EY 4.57 5.70 6.44 5.87 4.15 3.91 3.09 29.71%
DY 1.43 0.51 0.83 0.00 1.37 0.37 0.33 165.08%
P/NAPS 2.33 1.91 1.79 2.22 2.55 2.78 3.48 -23.41%
Price Multiplier on Announcement Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 23/02/23 09/11/22 16/08/22 17/05/22 15/02/22 18/11/21 17/08/21 -
Price 1.65 1.39 1.34 1.51 1.60 1.62 2.49 -
P/RPS 2.26 1.82 1.73 1.88 2.36 2.32 2.73 -11.80%
P/EPS 22.41 18.75 17.33 17.27 22.94 22.90 26.64 -10.85%
EY 4.46 5.33 5.77 5.79 4.36 4.37 3.75 12.21%
DY 1.39 0.48 0.75 0.00 1.44 0.41 0.40 128.90%
P/NAPS 2.39 2.04 2.00 2.25 2.42 2.49 2.86 -11.25%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment